Neurogen gets $100mm in private placement
Executive Summary
Neurogen (discovering drugs for neurological, inflammatory, and metabolic conditions) raised $100mm through the private placement of roughly 14mm common shares priced at $7 (a slight discount to the market average). Warburg Pincus and Baker Brothers Investments led the placement.
Deal Industry
- Pharmaceuticals
-
Digital Health
- Artificial Intelligence
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice